학술논문

Phase I trial of the topoisomerase I inhibitor GG211 as a 72-hour infusion
Document Type
Journal
Source
EUROPEAN JOURNAL OF CANCER; NOV 1995, 31A p928-p928, 1p. Supplement: 5
Subject
Language
English
ISSN
09598049